Administer Intramuscular Epinephrine Immediately
This patient is experiencing anaphylaxis and requires immediate intramuscular epinephrine (0.3 mg IM in the anterolateral thigh) as first-line treatment, followed by transfer to an emergency facility for observation. 1, 2
Clinical Reasoning
This 39-year-old woman presents with multisystem involvement after food ingestion: oral pruritus, respiratory symptoms (wheezing, shortness of breath, cough), cutaneous manifestations (hives), and gastrointestinal symptoms (nausea). This constellation of symptoms affecting two or more organ systems following allergen exposure defines anaphylaxis, regardless of hemodynamic stability.
Why Epinephrine is Essential
The presence of respiratory involvement (wheezing, dyspnea) combined with cutaneous symptoms (urticaria) after eating constitutes anaphylaxis requiring immediate epinephrine administration. 2, 3 While her vital signs are currently stable and she lacks oropharyngeal swelling, failure to administer epinephrine early has been repeatedly implicated in anaphylaxis fatalities. 2
Her history of moderate persistent asthma places her at higher risk for life-threatening food-induced anaphylaxis and resulting fatality. 3 This significantly lowers the threshold for aggressive treatment.
Specific Management Protocol
Immediate actions:
- Epinephrine 0.3 mg IM (1:1,000 solution) in the anterolateral thigh (vastus lateralis muscle) 1, 2
- Prepare to repeat every 5-15 minutes if symptoms persist or progress 2
- Call for emergency transport
Adjunctive treatments (concurrent, not sequential):
- Albuterol nebulizer (3 mL) for bronchospasm - particularly important given her asthma history 1, 2
- H1 antihistamine: diphenhydramine 25-50 mg (oral or IV) 1, 2
- H2 antihistamine: ranitidine 1
- Supplemental oxygen 1
- Place patient supine with legs elevated if tolerated 1
Critical Pitfalls to Avoid
Do not substitute antihistamines or bronchodilators for epinephrine. 2 While antihistamines relieve itching and urticaria, they do not address stridor, wheezing, gastrointestinal symptoms, or shock. Albuterol does not relieve airway edema and cannot substitute for epinephrine in anaphylaxis treatment. 2
Do not delay epinephrine based on stable vital signs. The guidelines explicitly state that milder allergic reactions (flushing, urticaria, mild angioedema) can be treated with antihistamines alone only with ongoing monitoring, and if there is a history of prior severe allergic reaction, epinephrine should be administered promptly and earlier in the course of treatment (at the onset of even mild symptoms). 1, 2 This patient has respiratory involvement, which exceeds "mild" criteria.
Post-Treatment Management
After epinephrine administration and emergency transport:
- Observe for 4-6 hours minimum (longer if severe symptoms) 1, 2
- Monitor for biphasic reactions (occur in 1-20% of cases, typically ~8 hours later) 3
- Discharge medications (2-3 days): 1, 2
- H1 antihistamine (diphenhydramine every 6 hours)
- H2 antihistamine (ranitidine twice daily)
- Corticosteroid (prednisone daily) - to potentially prevent biphasic/protracted reactions
- Prescribe two epinephrine auto-injectors (0.3 mg for adults >25 kg) 2, 3
- Provide written anaphylaxis emergency action plan 2
- Arrange allergist referral for identification of specific food allergen 2
Why Not Antihistamines Alone
While some might consider treating this as a "milder" reaction given stable vitals and absence of angioedema, the guidelines are clear: when antihistamines alone are given, ongoing observation is warranted to ensure lack of progression, and if progression is noted, epinephrine should be administered immediately. 1, 2 Given her high-risk features (asthma, respiratory symptoms already present), waiting for progression risks the delay that has been implicated in fatalities. The risk-benefit calculation strongly favors immediate epinephrine.
The patient's asthma history fundamentally changes the risk calculus - asthmatics, especially those with moderate-to-severe disease, are at substantially higher risk for fatal anaphylaxis. 3 This mandates more aggressive early intervention rather than watchful waiting.